AT363196B - Verfahren zur herstellung von androstan-17-on-derivaten - Google Patents

Verfahren zur herstellung von androstan-17-on-derivaten

Info

Publication number
AT363196B
AT363196B AT0504677A AT504677A AT363196B AT 363196 B AT363196 B AT 363196B AT 0504677 A AT0504677 A AT 0504677A AT 504677 A AT504677 A AT 504677A AT 363196 B AT363196 B AT 363196B
Authority
AT
Austria
Prior art keywords
androstan
derivatives
producing
producing androstan
Prior art date
Application number
AT0504677A
Other languages
German (de)
English (en)
Other versions
ATA504677A (de
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ATA504677A publication Critical patent/ATA504677A/de
Application granted granted Critical
Publication of AT363196B publication Critical patent/AT363196B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/005Degradation of the lateral chains at position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/863Mycobacterium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT0504677A 1976-07-16 1977-07-13 Verfahren zur herstellung von androstan-17-on-derivaten AT363196B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762632677 DE2632677A1 (de) 1976-07-16 1976-07-16 Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung

Publications (2)

Publication Number Publication Date
ATA504677A ATA504677A (de) 1980-12-15
AT363196B true AT363196B (de) 1981-07-10

Family

ID=5983514

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0504677A AT363196B (de) 1976-07-16 1977-07-13 Verfahren zur herstellung von androstan-17-on-derivaten

Country Status (18)

Country Link
US (1) US4179336A (member.php)
JP (1) JPS5315493A (member.php)
AT (1) AT363196B (member.php)
BE (1) BE856860A (member.php)
CH (3) CH627190A5 (member.php)
CS (1) CS200517B2 (member.php)
DD (4) DD136141A5 (member.php)
DE (1) DE2632677A1 (member.php)
DK (1) DK142372C (member.php)
FR (4) FR2365588A1 (member.php)
GB (1) GB1585786A (member.php)
HU (4) HU182789B (member.php)
IE (1) IE45304B1 (member.php)
IT (1) IT1077339B (member.php)
NL (1) NL7706638A (member.php)
SE (1) SE440779B (member.php)
SU (1) SU980628A3 (member.php)
YU (1) YU164277A (member.php)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55148083A (en) * 1979-05-04 1980-11-18 Mitsubishi Chem Ind Ltd Microorganism
JPS55150893A (en) * 1979-05-11 1980-11-25 Mitsubishi Chem Ind Ltd Novel microorganism
JPS578794A (en) * 1980-06-17 1982-01-18 Mitsubishi Chem Ind Ltd Preparation of androstane-type steroid
US4755463A (en) * 1982-05-25 1988-07-05 Wisconsin Alumni Research Foundation Process for preparing steroids
US4444884A (en) * 1982-05-25 1984-04-24 Wisconsin Alumni Research Foundation Process for preparing steroids
EP0738703B1 (en) * 1995-02-28 2002-05-22 Nippon Shokubai Co., Ltd. Acrylic acid derivatives, method for preparing the acrylic acid derivatives, and acrylic acid polymers
EP2644206B1 (en) * 2003-05-23 2019-04-03 Nektar Therapeutics PEG derivatives containing two PEG chains
EP2495242B1 (en) * 2009-10-29 2016-05-04 Industry-Academic Cooperation Foundation Yonsei University Novel vascular leak inhibitor
US9388210B2 (en) 2011-02-25 2016-07-12 Washington University Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
AU2012323888A1 (en) 2011-10-14 2014-05-29 Sage Therapeutics, Inc. 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
HRP20181048T1 (hr) 2012-12-18 2018-08-24 Washington University Neuroaktivni 19-alkoksi-17-supstituirani steroidi, korisni u postupcima liječenja
EP2956466A4 (en) 2013-02-15 2016-11-02 Univ Washington NEUROACTIVE ENANTIOMERS 15, 16 AND 17 SUBSTITUTED STEROIDS AS MODULATORS FOR GABA-A RECEPTORS
US9512170B2 (en) 2013-03-01 2016-12-06 Washington University Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
US9365502B2 (en) 2013-03-11 2016-06-14 Washington University Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
US9562026B2 (en) 2013-03-14 2017-02-07 Washington University Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
EP2986623B1 (en) 2013-04-17 2018-11-07 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
HUE051403T2 (hu) 2013-04-17 2021-03-01 Sage Therapeutics Inc Neuroaktív 19-nor-szteroidok kezelési eljárásokhoz
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
LT3021852T (lt) 2013-07-19 2021-04-12 Sage Therapeutics, Inc. Neuroaktyvūs steroidai, jų kompozicijos ir panaudojimas
EP3035940B1 (en) 2013-08-23 2018-10-17 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN112961206A (zh) 2014-10-16 2021-06-15 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
EP3206493B1 (en) 2014-10-16 2020-05-06 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
HUE049014T2 (hu) 2014-11-27 2020-09-28 Sage Therapeutics Inc Készítmények és módszerek a központi idegrendszer rendellenességeinek kezelésére
ES2857082T3 (es) 2015-01-26 2021-09-28 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos del SNC
US10329320B2 (en) 2015-02-20 2019-06-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
NZ790225A (en) 2016-07-11 2025-08-29 Sage Therapeutics Inc C17, C20, and C21 substituted neuroactive steroids and their methods of use
NZ790187A (en) 2016-07-11 2025-08-29 Sage Therapeutics Inc C7, C12, and C16 substituted neuroactive steroids and their methods of use
CN114206900A (zh) 2019-05-31 2022-03-18 萨奇治疗股份有限公司 神经活性类固醇及其组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3451892A (en) * 1965-10-19 1969-06-24 Schering Corp Process for the preparation of steroidal compounds
NL6705450A (member.php) * 1965-10-22 1968-10-21
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione
US3738983A (en) * 1971-08-06 1973-06-12 Searle & Co Process for the preparation of 3-(3beta,17beta-dihydroxyandrost-5-en-17alpha-yl) propionic acid gamma-lactone
DE2534911C2 (de) * 1975-08-01 1985-04-18 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 5-Androsten-17-on-Derivaten

Also Published As

Publication number Publication date
DD136141A5 (de) 1979-06-20
HU182790B (en) 1984-03-28
GB1585786A (en) 1981-03-11
DE2632677A1 (de) 1978-01-26
DK142372C (da) 1981-03-23
DD132439A5 (de) 1978-09-27
CH629222A5 (de) 1982-04-15
CS200517B2 (en) 1980-09-15
US4179336A (en) 1979-12-18
JPS6117477B2 (member.php) 1986-05-07
HU182789B (en) 1984-03-28
SU980628A3 (ru) 1982-12-07
HU182681B (en) 1984-02-28
ATA504677A (de) 1980-12-15
SE440779B (sv) 1985-08-19
FR2365588B1 (member.php) 1982-06-25
DE2632677C2 (member.php) 1988-06-16
DK142372B (da) 1980-10-20
CH627190A5 (member.php) 1981-12-31
DD137235A5 (de) 1979-08-22
IE45304L (en) 1978-01-16
IT1077339B (it) 1985-05-04
NL7706638A (nl) 1978-01-18
CH629503A5 (de) 1982-04-30
JPS5315493A (en) 1978-02-13
HU179344B (en) 1982-10-28
FR2365588A1 (fr) 1978-04-21
IE45304B1 (en) 1982-07-28
SE7708192L (sv) 1978-01-17
FR2372175A1 (fr) 1978-06-23
BE856860A (fr) 1978-01-16
FR2372174A1 (fr) 1978-06-23
DD136142A5 (de) 1979-06-20
YU164277A (en) 1982-08-31
DK323677A (da) 1978-01-17
FR2372176A1 (fr) 1978-06-23

Similar Documents

Publication Publication Date Title
ATA196177A (de) Verfahren zur herstellung von chlordioxid
AT363196B (de) Verfahren zur herstellung von androstan-17-on-derivaten
AT362782B (de) Verfahren zur herstellung von 4-hydroxypyrrolidin-2-on-derivaten
AT362781B (de) Verfahren zur herstellung von 4-hydroxypyrrolidin-2-on-derivaten
AT353251B (de) Verfahren zur herstellung von m- phenoxybenzaldehyd
AT358729B (de) Verfahren zur herstellung von 3-halogenmethyl-3 -cephemen
AT352138B (de) Verfahren zur herstellung von 2-chlorsulfinyl- azetidin-4-onen
AT347437B (de) Verfahren zur herstellung von benzoylcyanid
AT358197B (de) Verfahren zur herstellung von cholesterin- derivaten
AT347439B (de) Verfahren zur herstellung von benzoylcyanid
AT364817B (de) Verfahren zur herstellung von aminocyclolen
AT356129B (de) Verfahren zur herstellung von substituierten 1-carbamoyl-2-cyanaziridinen
DD131021A5 (de) Verfahren zur herstellung substituierter aminochinazolinderivate
AT347438B (de) Verfahren zur herstellung von benzoylcyanid
DD134228A5 (de) Verfahren zur herstellung von spirooxazolidindionen
AT374809B (de) Verfahren zur herstellung von alkalizellulose
AT355013B (de) Verfahren zur herstellung von 2-oxo-pyrrolidin- n-alkylamiden
DD130659A5 (de) Verfahren zur herstellung von oxothiaverbindungen
ATA966976A (de) Verfahren zur herstellung von 2-aminoindanderivaten
AT348512B (de) Verfahren zur herstellung von isoindol- derivaten
AT353790B (de) Verfahren zur herstellung von indolderivaten
AT382148B (de) Verfahren zur herstellung von chinazolinonderivaten
ATA378379A (de) Verfahren zur herstellung von nitroalkanolderivaten
AT352274B (de) Verfahren zur herstellung von 7-alkoxy-3- brommethylcephemen
AT388155B (de) Verfahren zur herstellung von chlordioxid

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee